Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    20167848 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dendritic Cell-based Immunotherapy in Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: tumor lysate-loaded autologous dendritic cells
2 Completed Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
Condition: Malignant (Pleural) Mesothelioma
Intervention: Biological: DC + CTX
3 Recruiting Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients
Condition: Mesothelioma
Intervention: Biological: MesoCancerVac
4 Recruiting Autologous Dendritic Cell Vaccination in Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Biological: dendritic cell vaccination plus chemotherapy

Study has passed its completion date and status has not been verified in more than two years.